Todd D. Macko
Known title: Chief Financial OfficerCIK: 0001830744
Associated companies
Transaction History
| IBO | ▼ Sell | Open Market | 43,400 | $24K | 3/27/2026 | View on chart |
| IBO | ▼ Sell | Open Market | 1,600 | $961 | 3/25/2026 | View on chart |
| IBO | ▼ Sell | Open Market | 43,400 | $24K | 3/27/2026 | View on chart |
| IBO | ▼ Sell | Open Market | 1,600 | $961 | 3/25/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Impact BioMedical (IBO) noted in after‑hours health‑care stock moves
IBO was listed among twelve health‑care companies that showed price movement in Wednesday’s after‑market session, according to Benzinga. The activity highlights recent investor interest in the stock. The move occurs while the share trades near its recent support level of $0.47.
Impact BioMedical (IBO) noted in after‑hours health‑care stock moves. IBO was listed among twelve health‑care companies that showed price movement in Wednesday’s after‑market session, according to Benzinga. The activity highlights recent investor interest in the stock. The move occurs while the share trades near its recent support level of $0.47.